Aromatherapy to Address Psychological Distress in Emergency Department Patients. (NCT07328412) | Clinical Trial Compass
CompletedNot Applicable
Aromatherapy to Address Psychological Distress in Emergency Department Patients.
United States60 participantsStarted 2026-02-02
Plain-language summary
The goal of this clinical trial is to understand the feasibility and acceptability of a brief aromatherapy session for reducing stress, anxiety, and improving patient satisfaction among emergency department patients. The main question the study aims to answer is: Is the intervention acceptable and feasible? Participants in the intervention group will receive a lavender-scented tube and smell it for about 5 minutes. Participants in the control group will receive an unscented tube and follow the same instructions.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adults ≥18 years of age
* Admitted to the BWH Emergency Department (ED) Observation Unit
* Able to provide written informed consent
* Willing to participate in a 1-hour aromatherapy session
Exclusion Criteria:
* Acutely ill and unable to be approached for research, as determined by the treating medical team and/or physician investigator
* Active gastrointestinal problems at the time of enrollment (e.g., nausea, vomiting, abdominal cramping, diarrhea), as determined by the treating team and/or physician investigator.
* Pregnancy or breastfeeding
* Current or planned treatment using sedating medications
* History of, or current presentation with, significant cognitive impairment or acute delirium that would preclude informed consent or participation
* Currently receiving supplemental oxygen
* Acute exacerbation of asthma or COPD
* Admission for an acute upper or lower respiratory tract illness (e.g., pneumonia, bronchitis, influenza, COVID-19)
* Known allergy or sensitivity to lavender
* Documented history of anosmia (loss of smell)
* Documented hypotension during current ED presentation, defined as systolic blood pressure \<90 mmHg
* Assigned clinical staff (physician, nurse, or other healthcare provider) with fragrance sensitivity prior to consent
* Concurrent enrollment in another interventional drug or behavioral trial
* Any condition that, in the judgment of the treating team or physician investigator, would make study participation unsafe or inapp…